FDA Inspection 1127573 — Eurofins Biopharma Product Testing Ireland Limited
The FDA completed an inspection of Eurofins Biopharma Product Testing Ireland Limited on Jan 17, 2019 in Dungarvan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jan 17, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dungarvan (Ireland)
Additional Details
Mutual Recognition Agreement (MRA)